StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
DTZ.AX$0.04-2.27%
Fair $0.04+0.0%

DTZ.AX

Dotz Nano Limited

Basic Materials / Specialty ChemicalsASX

$0.04

-0.00 (-2.27%)

Fairly Valued+0.0%Fair Value $0.04Fund rank 29/100 · Data gapFallback financials|
SA 37/D
F-Score: 1/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 22%

FCF escenarios

weak_data · normalized FCF $-3.2M · quality 57.0/100

Data gap 29/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 21/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

37/100

D

Piotroski

1/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

20/100

SEC 0%

Latest source: unknownPeriods: 5Warnings: 1unknown: 5
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. ROE is 2.7%, below the 5% threshold
Thesis & Journal · DTZ.AXLocal privado en este navegador · Dotz Nano Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$33M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

265.3%

↑

Gross Margin

62.4%

↑

Debt/Equity

-1.15

↓
52-Week Range$0
$0$0

TradingView lightweight chart

DTZ.AX price, volumen y niveles de valoración

Último $0.043Periodo -100.0%
Fair value: $0.043

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2021–2025 · 4 años de histórico normalizado

Revenue CAGR

-1.6%

FCF CAGR

—

FCF margin

-769.4%

FCF / Net income

0.24x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $285782.0 · net income $-9.1M · FCF $-2.2M

2021-FY → 2025-FY

Gross margin

62.4%+2.5% pts

Operating margin

-1352.7%— pts

Net margin

-3187.1%— pts

FCF margin

-769.4%— pts
MetricTTM
2025
2024
2023
2022
2021
Income Statement
Revenue$285782.00$285782.00—$53025.00$191900.00$304595.00
Net Income$-9.1M$-9.1M$-5.8M$-6.6M$-5.4M—
EBITDA$-6.6M$-6.6M$-4.3M$-5.1M$-4.8M—
EPS-0.02-0.02-0.01-0.01-0.01—
Gross Margin62.4%62.4%—76.4%27.3%59.9%
Operating Margin-1352.7%-1352.7%—-10465.2%-2584.5%—
Net Margin-3187.1%-3187.1%—-12389.4%-2800.1%—
Balance Sheet
Debt/Equity-1.15-1.15-0.071.40-11.81—
Current Ratio0.260.26————
Cash Flow
Free Cash Flow$-2.2M$-2.2M$-3.2M$-5.3M$-4.8M—
Returns
ROE265.3%265.3%13.3%-273.8%2196.9%—
Valuation
P/B———31.93——
Growth & Yield
Revenue Growth———-72.4%-37.0%—
EPS Growth-40.7%-40.7%21.2%-13.2%——

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -6.5%

Total return

-6.5%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.01 → -0.02

Residual

-6.5%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-6.5%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.